simple peptide semaglutide reviews Injections Kirkland & Bellevue Peptide of the Week: Semaglutide

As of April 2026, semaglutide is the most commercially successful pharmaceutical product in history by sales, and its clinical indication expansion continues

Because semaglutide itself can cause fatigue as a side effect, many patients and clinicians overlook creeping iron deficiency

Semaglutide often reduces appetite, and for some people, it also reduces thirst

Missing occasional doses is not typically harmful, but try to maintain consistent dosing

Clinical Evidence & Research Use Clinical evidence is essential for assessing the safety, efficacy, and long-term benefits of any therapy

The mechanism of action of these drugs, in simple terms, is that they mimic natural gut hormones (such as GLP-1, and in the case of tirzepatide, also GIP) which regulate appetite and satiety